RPA1 and cancer: Recent findings suggest that telomere replication and recombination intermediates in ALT-positive cancer cells are even transmitted to the next cell cycle, where they are shielded by RPA to prevent excessive telomere damage and promote a process termed post-mitotic DNA synthesis (post-MiDAS) in G1 cells (Lezaja et al. 2021).